Quantum Biopharma (QNTM) Cash from Discontinued Operations (2019 - 2022)

Quantum Biopharma has disclosed Cash from Discontinued Operations across 4 years of filings, most recently posting 504264.0 for Q1 2022.

• Cash from Discontinued Operations for Q1 2022 came in at 504264.0, down 175.04% year-over-year; the trailing twelve-month figure through Mar 2022 was 2558318.0 (down 1725.79% YoY), and the FY2022 annual result was 1142982.0, up 17.3% from the prior year.
• Cash from Discontinued Operations came in at 504264.0 for Q1 2022 at Quantum Biopharma, up from 2608536.0 in the prior quarter.
• In the past five years, Cash from Discontinued Operations ranged from a high of 1539547.64 in Q1 2019 to a low of 2608536.0 in Q4 2021.
• The 4-year median for Cash from Discontinued Operations is 80935.53 (2020), against an average of 95712.48.
• Across the five-year window, Cash from Discontinued Operations jumped 930.31% in 2021 and tumbled 175.04% in 2022, its largest moves.
• Quantum Biopharma's Cash from Discontinued Operations stood at 1539547.64 in 2019, then sank by 106.4% to 98471.34 in 2020, then tumbled by 2549.03% to 2608536.0 in 2021, then soared by 80.67% to 504264.0 in 2022.
• The last three Cash from Discontinued Operations figures came in at 504264.0 (Q1 2022), 2608536.0 (Q4 2021), and 314573.0 (Q3 2021), per Business Quant data.